ArticleJournal of medical Internet research2021
Risk Stratification for Early Detection of Diabetes and Hypertension in Resource-Limited Settings: Machine Learning Analysis.
Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 49 citations in OpenAlex.
- Cardiovascular Disease Screening Programs in Low- and Middle-Income Countries: A Systematic Review.JACC. Advances · 2026Article
- Prevalence, risk-factors and early prediction of impaired kidney function among indigenous adults in Odisha, India: A secondary analysis.The Indian journal of medical research · 2026Article
- Artificial intelligence in nephrology: predicting CKD progression and personalizing treatment.International urology and nephrology · 2026Review
- Explainable machine learning for hypertension prevalence classification: a cross-sectional study in Hainan Province, China.Frontiers in cardiovascular medicine · 2026Article
- Artificial intelligence in preventive care in primary health care settings: a scoping review.Archives of medical sciences. Atherosclerotic diseases · 2026Article
- Operationalising Inclusion for Participatory Design: Worked Examples for TRIPOD+AI & PROBAST+AI.Health services insights · 2026Article
- Risk Prediction of Unplanned Extubation in Inpatients Using Random Forest and Logistic Regression Models.Journal of patient safety · 2025Article
- Use of the FHTHWA Index as a Novel Approach for Predicting the Incidence of Diabetes in a Japanese Population Without Diabetes: Data Analysis Study.JMIR medical informatics · 2025Article
- Next-generation diabetes diagnosis and personalized diet-activity management: A hybrid ensemble paradigm.PloS one · 2025Article
- Validating Machine Learning Models Against the Saline Test Gold Standard for Primary Aldosteronism Diagnosis.JACC. Asia · 2024Article
- Shapely additive values can effectively visualize pertinent covariates in machine learning when predicting hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2023Article
- Digital Application of Clinical Staging to Support Stratification in Youth Mental Health Services: Validity and Reliability Study.JMIR formative research · 2023Article
- Machine learning for predicting diabetes risk in western China adults.Diabetology & metabolic syndrome · 2023Article
- Survey and Evaluation of Hypertension Machine Learning Research.Journal of the American Heart Association · 2023Article
- Development of a convenient and effective hypertension risk prediction model and exploration of the relationship between Serum Ferritin and Hypertension Risk: a study based on NHANES 2017-March 2020.Frontiers in cardiovascular medicine · 2023Article
- Development and validation of a machine learning-augmented algorithm for diabetes screening in community and primary care settings: A population-based study.Frontiers in endocrinology · 2022Article
- Machine learning for diabetes clinical decision support: a review.Advances in computational intelligence · 2022Review
- Machine Learning Approaches for Predicting Hypertension and Its Associated Factors Using Population-Level Data From Three South Asian Countries.Frontiers in cardiovascular medicine · 2022Article
- Machine learning and deep learning predictive models for type 2 diabetes: a systematic review.Diabetology & metabolic syndrome · 2021Review
- Predictability of COVID-19 Hospitalizations, Intensive Care Unit Admissions, and Respiratory Assistance in Portugal: Longitudinal Cohort Study.Journal of medical Internet research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe impending scale up of noncommunicable disease screening programs in low- and middle-income countries coupled with limited health resources require that such programs be as accurate as possible at identifying patients at high risk.
objectiveThe aim of this study was to develop machine learning-based risk stratification algorithms for diabetes and hypertension that are tailored for the at-risk population served by community-based screening programs in low-resource settings.
methodsWe trained and tested our models by using data from 2278 patients collected by community health workers through door-to-door and camp-based screenings in the urban slums of Hyderabad, India between July 14, 2015 and April 21, 2018. We determined the best models for predicting short-term (2-month) risk of diabetes and hypertension (a model for diabetes and a model for hypertension) and compared these models to previously developed risk scores from the United States and the United Kingdom by using prediction accuracy as characterized by the area under the receiver operating characteristic curve (AUC) and the number of false negatives.
resultsWe found that models based on random forest had the highest prediction accuracy for both diseases and were able to outperform the US and UK risk scores in terms of AUC by 35.5% for diabetes (improvement of 0.239 from 0.671 to 0.910) and 13.5% for hypertension (improvement of 0.094 from 0.698 to 0.792). For a fixed screening specificity of 0.9, the random forest model was able to reduce the expected number of false negatives by 620 patients per 1000 screenings for diabetes and 220 patients per 1000 screenings for hypertension. This improvement reduces the cost of incorrect risk stratification by US $1.99 (or 35%) per screening for diabetes and US $1.60 (or 21%) per screening for hypertension.
conclusionsIn the next decade, health systems in many countries are planning to spend significant resources on noncommunicable disease screening programs and our study demonstrates that machine learning models can be leveraged by these programs to effectively utilize limited resources by improving risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.